Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response

Alessia Garufi; Gianandrea Traversi; Maria Saveria Gilardini Montani; Valerio D’Orazi; Giuseppa Pistritto; Mara Cirone; Gabriella D’Orazi

doi:10.18632/oncotarget.27087

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response

Alessia Garufi, Gianandrea Traversi, Maria Saveria Gilardini Montani, Valerio D’Orazi, Giuseppa Pistritto, Mara Cirone and Gabriella D’Orazi _

PDF | Full Text | How to cite

Oncotarget. 2019; 10:4691-4702. https://doi.org/10.18632/oncotarget.27087

Metrics: PDF 1119 views | Full Text 1826 views | ?

Abstract

Alessia Garufi1^,2^,*, Gianandrea Traversi1^,2^,*, Maria Saveria Gilardini Montani3, Valerio D’Orazi4, Giuseppa Pistritto5, Mara Cirone3 and Gabriella D’Orazi1^,2

1 IRCCS Regina Elena National Cancer Institute, Department of Research, Rome 00144, Italy

2 University ‘G. d’Annunzio’, Department of Medical and Biotechnological Sciences, Chieti 66013, Italy

3 Sapienza University, Department of Experimental Medicine, Rome 00161, Italy

4 Department of Surgical Sciences, Rome 00161, Italy

5 University Tor Vergata, Department of Systems Medicine, Rome 00133, Italy

* These authors contributed equally to this work

Correspondence to:

Gabriella D’Orazi,

email:

[email protected]

Keywords: chemoresistance; reactive oxygen species (ROS); high glucose (HG); cancer; nuclear factor erythroid 2-related factor 2 (NRF2)

Received: April 23, 2019 Accepted: July 05, 2019 Published: July 23, 2019

ABSTRACT

Resistance to chemotherapy represents a major obstacle to successful treatment. The generation of reactive oxygen species (ROS) has been directly linked to the cytotoxic effects of several antitumor agents, including Adriamycin (ADR), and modulation of the oxidative balance has been implicated in the development and/or regulation of resistance to chemotherapeutic drugs. We recently showed that high glucose (HG) markedly diminished the cancer cell death induced by anticancer agents such as ADR. In the present study we attempted to evaluate the mechanism that impaired the cytotoxic effect of ADR in HG. We found that, in colon cancer cells, HG attenuated ADR-induced ROS production that consequently diminished ADR-induced H2AX phosphorylation and micronuclei (MN) formation. Mechanistically, HG attenuation of ADR-induced ROS production correlated with increased antioxidant response promoted by NRF2 activity. Thus, pharmacologic inhibition of NRF2 pathway by brusatol re-established the ADR cytotoxic effect impaired by HG. Together, the data provide new insights into chemotherapeutic-resistance mechanisms in HG condition dictated by increased NRF2-induced antioxidant response and how they may be overcome in order to restore chemosensitivity and ADR-induced cell death.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27087

Publication Alerts

Research Papers:

Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response

Abstract